Detalhe da pesquisa
1.
Immune-Related Diarrhea and Colitis in Non-small Cell Lung Cancers: Impact of Multidisciplinary Management in a Real-World Setting.
Oncologist
; 29(1): e118-e130, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37603442
2.
Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World.
Oncologist
; 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520745
3.
Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With Outcome.
Oncologist
; 27(2): e199-e202, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641202
4.
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study.
Oncologist
; 27(2): 87-e115, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641222
5.
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 22(10): 1438-1447, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34499874
6.
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines.
Future Oncol
; 17(19): 2513-2527, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33988036
7.
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience.
Oncologist
; 25(12): e1996-e2005, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32557976
8.
Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment.
Int J Mol Sci
; 21(5)2020 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32111093
9.
From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study).
Oncologist
; 24(6): e318-e326, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30846513
10.
Detection of Loss of Heterozygosity in cfDNA of Advanced EGFR- or KRAS-Mutated Non-Small-Cell Lung Cancer Patients.
Int J Mol Sci
; 21(1)2019 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31861832
11.
The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: Focus on small cell lung cancer.
Cancer Treat Rev
; 128: 102768, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38797062
12.
Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients.
Front Immunol
; 15: 1308109, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38348046
13.
Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis.
Front Immunol
; 15: 1353889, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38322260
14.
Diagnostic-Therapeutic Pathway and Outcomes of Early Stage NSCLC: a Focus on EGFR Testing in the Real-World.
Front Oncol
; 12: 909064, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35847912
15.
The Multidisciplinary Approach in Stage III Non-Small Cell Lung Cancer over Ten Years: From Radiation Therapy Optimisation to Innovative Systemic Treatments.
Cancers (Basel)
; 14(22)2022 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36428792
16.
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome.
Transl Lung Cancer Res
; 10(1): 202-220, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33569305
17.
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center.
Front Oncol
; 11: 669786, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34262861
18.
Novel Nuclear Medicine Imaging Applications in Immuno-Oncology.
Cancers (Basel)
; 12(5)2020 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32455666
19.
Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer.
Front Oncol
; 10: 564915, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33072595
20.
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non-small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy.
Clin Lung Cancer
; 21(1): 1-14.e3, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601525